SMAD7 and cancer: Most notably, many of these early response alterations in the cancer cells are known pro‐angiogenic transcripts, including ITGA2 [45], CLDN12 [46], SMAD7 [47], MET [48], KLF4 [49, 50], ID3 [51] and ID1 [51].